Mammalian Target of Rapamycin: Hitting the Bull's-Eye for Neurological Disorders
暂无分享,去创建一个
Yan Chen Shang | Kenneth Maiese | Shaohui Wang | K. Maiese | Zhao Zhong (兆忠) Chong (种) | Y. Shang | Zhao Zhong Chong | Lijie Zhang | Shaohui Wang | Lijie Zhang
[1] Hui Jin,et al. The neuroprotective effects of tanshinone IIA on β-amyloid-induced toxicity in rat cortical neurons , 2010, Neuropharmacology.
[2] N. Shaik,et al. Increased frequency of micronuclei in diabetes mellitus patients using pioglitazone and glimepiride in combination. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[3] N. Kashihara,et al. Oxidative stress in diabetic nephropathy. , 2010, Current medicinal chemistry.
[4] I. Kawamura,et al. Erythropoietin receptor signaling mitigates renal dysfunction-associated heart failure by mechanisms unrelated to relief of anemia. , 2010, Journal of the American College of Cardiology.
[5] N. Chauhan,et al. Synergistic benefits of erythropoietin and simvastatin after traumatic brain injury , 2010, Brain Research.
[6] Jacob E. Montgomery,et al. The inhibitor of phagocytosis, O-phospho-L-serine, suppresses Müller glia proliferation and cone cell regeneration in the light-damaged zebrafish retina. , 2010, Experimental eye research.
[7] H. Matsubara,et al. Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[8] Wei Yan,et al. The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice , 2010, Acta Pharmacologica Sinica.
[9] Yunfei Huang,et al. Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy , 2010, Neurobiology of Disease.
[10] A. Takahashi,et al. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status. , 2010, International journal of oncology.
[11] A. Saluja,et al. Autophagy in pancreatic cancer , 2010, Autophagy.
[12] E. Klann,et al. Dysregulation of the mTOR Pathway Mediates Impairment of Synaptic Plasticity in a Mouse Model of Alzheimer's Disease , 2010, PloS one.
[13] L. Hu,et al. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats , 2010, Neuroscience.
[14] K. Maiese,et al. Wnt1, FoxO3a, and NF-kappaB oversee microglial integrity and activation during oxidant stress. , 2010, Cellular signalling.
[15] P. Ponikowski,et al. EPO's rescue mission in acute myocardial infarction: still more hopes than evidence. , 2010, European heart journal.
[16] J. D. Young,et al. Bench to bedside: A role for erythropoietin in sepsis , 2010, Critical care.
[17] D. Goberdhan,et al. Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation , 2010, Oncogene.
[18] O. Steward,et al. PTEN Deletion Enhances the Regenerative Ability of Adult Corticospinal Neurons , 2010, Nature Neuroscience.
[19] M. Gambello,et al. Mammalian Target of Rapamycin (mTOR) Activation Increases Axonal Growth Capacity of Injured Peripheral Nerves* , 2010, The Journal of Biological Chemistry.
[20] L. Platanias,et al. Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells , 2010, Proceedings of the National Academy of Sciences.
[21] K. Maiese,et al. FOXO3a governs early and late apoptotic endothelial programs during elevated glucose through mitochondrial and caspase signaling , 2010, Molecular and Cellular Endocrinology.
[22] C. Ching,et al. Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma. , 2010, The American journal of pathology.
[23] D. Ouwens,et al. Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1. , 2010, Cellular signalling.
[24] F. Costes,et al. Downregulation of Akt/mammalian target of rapamycin pathway in skeletal muscle is associated with increased REDD1 expression in response to chronic hypoxia. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.
[25] T. P. Neufeld,et al. Regulation of mTORC1 by the Rab and Arf GTPases* , 2010, The Journal of Biological Chemistry.
[26] A. Nakashima,et al. Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer , 2010, Oncogene.
[27] Lisette Schoonhoven,et al. Endotoxemia-induced inflammation and the effect on the human brain , 2010, Critical care.
[28] James W. Fawcett,et al. The role of local protein synthesis and degradation in axon regeneration , 2010, Experimental Neurology.
[29] K. Maiese,et al. Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation. , 2010, Current neurovascular research.
[30] Chang Hwa Jung,et al. mTOR regulation of autophagy , 2010, FEBS letters.
[31] Jayanta Debnath,et al. Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease , 2010, PloS one.
[32] Jing Ji,et al. Activation of mTOR signaling pathway contributes to survival of cervical cancer cells. , 2010, Gynecologic oncology.
[33] D. Sabatini,et al. Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids , 2010, Cell.
[34] N. Demartines,et al. Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo , 2010, Molecular Cancer.
[35] J. Downward,et al. Rictor is a novel target of p70 S6 kinase-1 , 2010, Oncogene.
[36] E. Klann,et al. mTOR signaling: At the crossroads of plasticity, memory and disease , 2010, Trends in Neurosciences.
[37] K. Maiese,et al. Diabetes mellitus: channeling care through cellular discovery. , 2010, Current neurovascular research.
[38] Baoshan Xu,et al. Hydrogen peroxide inhibits mTOR signaling by activation of AMPKα leading to apoptosis of neuronal cells , 2010, Laboratory Investigation.
[39] Sang-Tae Kim,et al. A novel mTOR activating protein protects dopamine neurons against oxidative stress by repressing autophagy related cell death , 2010, Journal of neurochemistry.
[40] H. Lane,et al. Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells , 2009, Proceedings of the National Academy of Sciences.
[41] D. Fingar,et al. mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action* , 2009, The Journal of Biological Chemistry.
[42] Y. Le Marchand-Brustel,et al. Insulin Induces REDD1 Expression through Hypoxia-inducible Factor 1 Activation in Adipocytes* , 2009, The Journal of Biological Chemistry.
[43] Philippe P Roux,et al. mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling , 2009, Molecular and Cellular Biology.
[44] E. López-Bonet,et al. Serine 2481-autophosphorylation of mammalian target of rapamycin (mTOR) couples with chromosome condensation and segregation during mitosis: confocal microscopy characterization and immunohistochemical validation of PP-mTOR(Ser2481) as a novel high-contrast mitosis marker in breast cancer core biops , 2009, International journal of oncology.
[45] F. Gaytán,et al. The mammalian target of rapamycin as novel central regulator of puberty onset via modulation of hypothalamic Kiss1 system. , 2009, Endocrinology.
[46] Yan Chen Shang,et al. FoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis. , 2009, Current neurovascular research.
[47] Kathryn G. Foster,et al. Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser863 and Multisite Phosphorylation* , 2009, The Journal of Biological Chemistry.
[48] K. Maiese,et al. Erythropoietin, Forkhead Proteins, and Oxidative Injury: Biomarkers and Biology , 2009, TheScientificWorldJournal.
[49] D. A. Foster. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. , 2009, Biochimica et biophysica acta.
[50] J. Koh,et al. Oxidative injury triggers autophagy in astrocytes: The role of endogenous zinc , 2009, Glia.
[51] K. Maiese,et al. The Vitamin Nicotinamide: Translating Nutrition into Clinical Care , 2009, Molecules.
[52] J. Asara,et al. Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1 , 2009, Molecular and Cellular Biology.
[53] M. Guglielmotto,et al. Oxidative Stress and Hypoxia Contribute to Alzheimer's Disease Pathogenesis: Two Sides of the Same Coin , 2009, TheScientificWorldJournal.
[54] Chin-Lee Wu,et al. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. , 2009, Cancer research.
[55] P. Greengard,et al. Inhibition of mTOR Signaling in Parkinson’s Disease Prevents l-DOPA–Induced Dyskinesia , 2009, Science Signaling.
[56] K. Maiese,et al. A fork in the path , 2009, Oxidative medicine and cellular longevity.
[57] P. Buckmaster,et al. Inhibition of the Mammalian Target of Rapamycin Signaling Pathway Suppresses Dentate Granule Cell Axon Sprouting in a Rodent Model of Temporal Lobe Epilepsy , 2009, The Journal of Neuroscience.
[58] I. Izquierdo,et al. BDNF Activates mTOR to Regulate GluR1 Expression Required for Memory Formation , 2009, PloS one.
[59] M. A. Moro,et al. mTOR/S6 Kinase Pathway Contributes to Astrocyte Survival during Ischemia* , 2009, The Journal of Biological Chemistry.
[60] H. Lane,et al. Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis , 2009, Molecular Cancer.
[61] Guoqiang Chen,et al. mTOR Signaling Pathway Is a Target for the Treatment of Colorectal Cancer , 2009, Annals of Surgical Oncology.
[62] M. Hengstschläger,et al. Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle , 2009, Human molecular genetics.
[63] R. Amato,et al. A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer , 2009, Cancer.
[64] T. Sturgill,et al. Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity Is Associated with Phosphorylation of Raptor by mTOR* , 2009, Journal of Biological Chemistry.
[65] L. Zeng,et al. The Mammalian Target of Rapamycin Signaling Pathway Mediates Epileptogenesis in a Model of Temporal Lobe Epilepsy , 2009, The Journal of Neuroscience.
[66] A. Shiau,et al. Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells , 2009, Autophagy.
[67] A. Nakashima,et al. Specific Activation of mTORC1 by Rheb G-protein in Vitro Involves Enhanced Recruitment of Its Substrate Protein* , 2009, Journal of Biological Chemistry.
[68] D. Kwiatkowski,et al. Tuberous Sclerosis Complex Activity Is Required to Control Neuronal Stress Responses in an mTOR-Dependent Manner , 2009, The Journal of Neuroscience.
[69] D. Sabatini,et al. DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival , 2009, Cell.
[70] J. Guan,et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. , 2009, Molecular biology of the cell.
[71] K. Maiese,et al. New strategies for Alzheimer disease and cognitive impairment , 2009, Oxidative medicine and cellular longevity.
[72] S. Andò,et al. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells. , 2009, The international journal of biochemistry & cell biology.
[73] Jeffrey P. MacKeigan,et al. Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.
[74] B. Hu,et al. Trace amounts of copper exacerbate beta amyloid-induced neurotoxicity in the cholesterol-fed mice through TNF-mediated inflammatory pathway , 2009, Brain, Behavior, and Immunity.
[75] P. Włodarski,et al. Fibroblasts from normal skin of a tuberous sclerosis patient show upregulation of mTOR pathway. , 2009, The American Journal of dermatopathology.
[76] Jeremy T. Smith. Sex steroid control of hypothalamic Kiss1 expression in sheep and rodents: Comparative aspects , 2009, Peptides.
[77] K. Maiese,et al. The forkhead transcription factor FOXO3a controls microglial inflammatory activation and eventual apoptotic injury through caspase 3. , 2009, Current neurovascular research.
[78] S. Codeluppi,et al. The Rheb–mTOR Pathway Is Upregulated in Reactive Astrocytes of the Injured Spinal Cord , 2009, The Journal of Neuroscience.
[79] Qing Lu,et al. DDPH ameliorated oxygen and glucose deprivation-induced injury in rat hippocampal neurons via interrupting Ca2+ overload and glutamate release. , 2009, European journal of pharmacology.
[80] Jeffrey W. Clark,et al. Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[81] Xiao-qing Tian,et al. Combined Inhibition of MEK and mTOR Signaling Inhibits Initiation and Progression of Colorectal Cancer , 2009, Cancer investigation.
[82] L. Greene,et al. RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation , 2008, The Journal of Neuroscience.
[83] K. Maiese,et al. Clever cancer strategies with FoxO transcription factors , 2008, Cell cycle.
[84] Derek Y. Chiang,et al. Pivotal role of mTOR signaling in hepatocellular carcinoma. , 2008, Gastroenterology.
[85] A. Erol. Unraveling the molecular mechanisms behind the metabolic basis of sporadic Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.
[86] Miguel Torres,et al. A new in vitro model of the glial scar inhibits axon growth , 2008, Glia.
[87] Zhigang He,et al. Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway , 2008, Science.
[88] P. Koh. Melatonin prevents ischemic brain injury through activation of the mTOR/p70S6 kinase signaling pathway , 2008, Neuroscience Letters.
[89] Jing Wang,et al. Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. , 2008, Learning & memory.
[90] K. Maiese,et al. Therapeutic promise and principles Metabotropic glutamate receptors , 2008 .
[91] Margit Rosner,et al. Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. , 2008, Human molecular genetics.
[92] D. Good,et al. Nerve growth factor inhibits Na+/H+ exchange and formula absorption through parallel phosphatidylinositol 3-kinase-mTOR and ERK pathways in thick ascending limb. , 2008, The Journal of biological chemistry.
[93] Philippe P Roux,et al. Oncogenic MAPK Signaling Stimulates mTORC1 Activity by Promoting RSK-Mediated Raptor Phosphorylation , 2008, Current Biology.
[94] N. Demartines,et al. mTORC2 regulates PGE2-mediated endothelial cell survival and migration. , 2008, Biochemical and biophysical research communications.
[95] L. French,et al. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis , 2008, The British journal of dermatology.
[96] S. Ceman,et al. S6K1 Phosphorylates and Regulates Fragile X Mental Retardation Protein (FMRP) with the Neuronal Protein Synthesis-dependent Mammalian Target of Rapamycin (mTOR) Signaling Cascade* , 2008, Journal of Biological Chemistry.
[97] J. Šantorová,et al. Mitochondrial oxidative phosphorylation and energetic status are reflected by morphology of mitochondrial network in INS-1E and HEP-G2 cells viewed by 4Pi microscopy. , 2008, Biochimica et biophysica acta.
[98] C. Powell,et al. Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation , 2008, Neurobiology of Learning and Memory.
[99] C. Simone. Signal-dependent control of autophagy and cell death in colorectal cancer cell: the role of the p38 pathway. , 2008, Autophagy.
[100] K. Maiese,et al. Rogue proliferation versus restorative protection: Where do we draw the line for Wnt and Forkhead signaling? , 2008, Expert opinion on therapeutic targets.
[101] David M. Sabatini,et al. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.
[102] T. Harris,et al. Regulation of Proline-rich Akt Substrate of 40 kDa (PRAS40) Function by Mammalian Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation* , 2008, Journal of Biological Chemistry.
[103] Rochelle M. Witt,et al. Pam (Protein associated with Myc) functions as an E3 ubiquitin ligase and regulates TSC/mTOR signaling. , 2008, Cellular signalling.
[104] K. Maiese,et al. Erythropoietin: Elucidating new cellular targets that broaden therapeutic strategies , 2008, Progress in Neurobiology.
[105] E. Tremoli,et al. In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function. , 2008, Cardiovascular research.
[106] H. Lane,et al. Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function , 2008, The Journal of Neuroscience.
[107] M. Kim,et al. Estradiol attenuates the focal cerebral ischemic injury through mTOR/p70S6 kinase signaling pathway , 2008, Neuroscience Letters.
[108] K. Maiese,et al. OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins. , 2008, Trends in molecular medicine.
[109] K. Maiese,et al. Erythropoietin and oxidative stress. , 2008, Current neurovascular research.
[110] B. Turk,et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.
[111] B. Manning,et al. The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2 , 2008, Molecular and Cellular Biology.
[112] K. Maiese,et al. Raves and risks for erythropoietin. , 2008, Cytokine & growth factor reviews.
[113] Yan Luo,et al. MAPK and mTOR pathways are involved in cadmium‐induced neuronal apoptosis , 2008, Journal of neurochemistry.
[114] K. Maiese,et al. The Wnt signaling pathway: aging gracefully as a protectionist? , 2008, Pharmacology & therapeutics.
[115] D. Gutmann,et al. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex , 2008, Annals of neurology.
[116] B. Bay,et al. Heat Shock Proteins and Neurodegenerative Disorders , 2008, TheScientificWorldJournal.
[117] D. Gutmann,et al. Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma. , 2008, Cancer research.
[118] P. Lambin,et al. The mTOR target 4E‐BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency , 2008, Proteomics.
[119] Lixin Wei,et al. Synergistic effect of mTOR inhibitor rapamycin and fluorouracil in inducing apoptosis and cell senescence in hepatocarcinoma cells , 2008, Cancer biology & therapy.
[120] M. Andersson,et al. Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer , 2008, International Journal of Clinical Oncology.
[121] K. Hsu,et al. Phosphatidylinositol 3-Kinase Activation Is Required for Stress Protocol-induced Modification of Hippocampal Synaptic Plasticity* , 2008, Journal of Biological Chemistry.
[122] D. Chinkes,et al. Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle. , 2008, American journal of physiology. Endocrinology and metabolism.
[123] P. Houghton,et al. mTORC1 Signaling Can Regulate Growth Factor Activation of p44/42 Mitogen-activated Protein Kinases through Protein Phosphatase 2A* , 2008, Journal of Biological Chemistry.
[124] D. Sgroi,et al. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. , 2008, Genes & development.
[125] H. Okabe,et al. RB1CC1 insufficiency causes neuronal atrophy through mTOR signaling alteration and involved in pathology of Alzheimer's diseases , 2007, Neuroscience Research.
[126] S. Ceman,et al. FMRP Phosphorylation Reveals an Immediate-Early Signaling Pathway Triggered by Group I mGluR and Mediated by PP2A , 2007, The Journal of Neuroscience.
[127] Joseph Gera,et al. mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. , 2007, Cancer research.
[128] M. Korbonits,et al. Octreotide and the mTOR Inhibitor RAD001 (Everolimus) Block Proliferation and Interact with the Akt-mTOR-p70S6K Pathway in a Neuro-Endocrine Tumour Cell Line , 2007, Neuroendocrinology.
[129] X. Bai,et al. Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38 , 2007, Science.
[130] K. Maiese,et al. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. , 2007, Histology and histopathology.
[131] Reham M. Abdel-Kader,et al. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? , 2007, Antioxidants & redox signaling.
[132] S. Dulchavsky,et al. CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells. , 2007, Anticancer research.
[133] A. Marx,et al. The insulin-like growth factor-I-mTOR signaling pathway induces the mitochondrial pyrimidine nucleotide carrier to promote cell growth. , 2007, Molecular biology of the cell.
[134] W. Buczko,et al. 1‐Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti‐thrombotic activity mediated by a cyclooxygenase‐2/prostacyclin pathway , 2007, British journal of pharmacology.
[135] S. Schreiber,et al. Small Molecule Enhancers of Rapamycin-Induced TOR Inhibition Promote Autophagy, Reduce Toxicity in Huntington’s Disease Models and Enhance Killing of Mycobacteria by Macrophages , 2007, Autophagy.
[136] H. Osago,et al. Elevation of Cellular NAD Levels by Nicotinic Acid and Involvement of Nicotinic Acid Phosphoribosyltransferase in Human Cells* , 2007, Journal of Biological Chemistry.
[137] C. Proud,et al. PRAS40 Is a Target for Mammalian Target of Rapamycin Complex 1 and Is Required for Signaling Downstream of This Complex* , 2007, Journal of Biological Chemistry.
[138] M. Guba,et al. Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis , 2007, Cancer and Metastasis Reviews.
[139] G. Hou,et al. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. , 2007, Cancer letters.
[140] O. Dormond,et al. The Effects of mTOR-Akt Interactions on Anti-apoptotic Signaling in Vascular Endothelial Cells* , 2007, Journal of Biological Chemistry.
[141] J. Gutkind,et al. P-Rex1 Links Mammalian Target of Rapamycin Signaling to Rac Activation and Cell Migration* , 2007, Journal of Biological Chemistry.
[142] M. Pallàs,et al. Implication of the transcription factor E2F-1 in the modulation of neuronal apoptosis. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[143] D. Alessi,et al. Identification of Protor as a novel Rictor-binding component of mTOR complex-2. , 2007, The Biochemical journal.
[144] T. Aw,et al. Neuronal apoptosis in neurodegeneration. , 2007, Antioxidants & redox signaling.
[145] R. Roth,et al. PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding* , 2007, Journal of Biological Chemistry.
[146] I. Deary,et al. A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition , 2007, BMC Genetics.
[147] M. Regulska,et al. Inhibitory effects of 1,25-dihydroxyvitamin D3 and its low-calcemic analogues on staurosporine-induced apoptosis. , 2007, Pharmacological reports : PR.
[148] V. Ravindranath,et al. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death‐associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by α‐lipoic acid , 2007 .
[149] C. Rhee,et al. Hypoxic condition- and high cell density-induced expression of Redd1 is regulated by activation of hypoxia-inducible factor-1alpha and Sp1 through the phosphatidylinositol 3-kinase/Akt signaling pathway. , 2007, Cellular signalling.
[150] K. Maiese,et al. Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways. , 2007, Cellular signalling.
[151] G. Moriceau,et al. mTOR inhibitors (rapamycin and its derivatives) and nitrogen containing bisphosphonates: bi-functional compounds for the treatment of bone tumours. , 2007, Current medicinal chemistry.
[152] Bingren Hu,et al. Alterations in Mammalian Target of Rapamycin Signaling Pathways after Traumatic Brain Injury , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[153] W. Colledge,et al. Hypogonadotrophic hypogonadism in mice lacking a functional Kiss-1 gene , 2007 .
[154] W. Klein,et al. Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine* , 2007, Journal of Biological Chemistry.
[155] E. Shohami,et al. Rapamycin is a neuroprotective treatment for traumatic brain injury , 2007, Neurobiology of Disease.
[156] G. Holmes,et al. Tuberous Sclerosis Complex and Epilepsy: Recent Developments and Future Challenges , 2007, Epilepsia.
[157] S. Carr,et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. , 2007, Molecular cell.
[158] Timothy J. Griffin,et al. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 , 2007, Nature Cell Biology.
[159] K. Maiese,et al. The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection. , 2007, International journal of molecular medicine.
[160] G. Gafford,et al. Translational Control via the Mammalian Target of Rapamycin Pathway Is Critical for the Formation and Stability of Long-Term Fear Memory in Amygdala Neurons , 2006, The Journal of Neuroscience.
[161] J. Freedman,et al. Thrombin‐triggered platelet apoptosis , 2006, Journal of thrombosis and haemostasis : JTH.
[162] D. Guertin,et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.
[163] J. Qin,et al. SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.
[164] M. Paccalin,et al. Activated mTOR and PKR Kinases in Lymphocytes Correlate with Memory and Cognitive Decline in Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.
[165] T. Maeda,et al. Nutrient-dependent Multimerization of the Mammalian Target of Rapamycin through the N-terminal HEAT Repeat Region* , 2006, Journal of Biological Chemistry.
[166] Lloyd A Greene,et al. RTP801 Is Elevated in Parkinson Brain Substantia Nigral Neurons and Mediates Death in Cellular Models of Parkinson's Disease by a Mechanism Involving Mammalian Target of Rapamycin Inactivation , 2006, The Journal of Neuroscience.
[167] Jacob D. Jaffe,et al. mSin1 Is Necessary for Akt/PKB Phosphorylation, and Its Isoforms Define Three Distinct mTORC2s , 2006, Current Biology.
[168] Ramkumar Veppathur Mohan,et al. mTOR Inhibition Induces Endothelial Progenitor Cell Death , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[169] O. Hino,et al. Neuromuscular abundance of RB1CC1 contributes to the non-proliferating enlarged cell phenotype through both RB1 maintenance and TSC1 degradation. , 2006, International journal of molecular medicine.
[170] Hideyuki Okano,et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice , 2006, Nature.
[171] George Thomas,et al. Hypothalamic mTOR Signaling Regulates Food Intake , 2006, Science.
[172] T Nakazato,et al. Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel. , 2006, European journal of cancer.
[173] K. Maiese,et al. Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress. , 2006, Current neurovascular research.
[174] Sathish Kumar Mungamuri,et al. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. , 2006, Cancer research.
[175] C. Walker,et al. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning , 2006, The Journal of cell biology.
[176] D. Sabatini,et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.
[177] I. Paul,et al. Nicotinamide reduces hypoxic ischemic brain injury in the newborn rat , 2006, Brain Research Bulletin.
[178] K. Maiese,et al. Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide. , 2006, Current medicinal chemistry.
[179] D. G. Herrera,et al. Nicotinamide Protects against Ethanol-Induced Apoptotic Neurodegeneration in the Developing Mouse Brain , 2006, PLoS medicine.
[180] Russell G. Jones,et al. Hypoxia-induced energy stress regulates mRNA translation and cell growth. , 2006, Molecular cell.
[181] D. Rubinsztein,et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. , 2006, Human molecular genetics.
[182] K. Maiese,et al. Attempted cell cycle induction in post-mitotic neurons occurs in early and late apoptotic programs through Rb, E2F1, and caspase 3. , 2006, Current neurovascular research.
[183] J. Dichgans,et al. Enhanced episodic‐like memory and kindling epilepsy in a rat model of tuberous sclerosis , 2006, Journal of neurochemistry.
[184] K. Maiese,et al. Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors. , 2005, Current neurovascular research.
[185] Steven P. Gygi,et al. mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events , 2005, Cell.
[186] D. Gutmann,et al. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. , 2005, Cancer research.
[187] N. Sonenberg,et al. Akt Activates the Mammalian Target of Rapamycin by Regulating Cellular ATP Level and AMPK Activity* , 2005, Journal of Biological Chemistry.
[188] J. Rafols,et al. Cerebral ischemia induced apoptosis and necrosis in normal and diabetic rats , 2005, Brain Research.
[189] Wolfgang Eiermann,et al. Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[190] A. V. D. van den Ouweland,et al. Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. , 2005, Biochemical and biophysical research communications.
[191] T. Motyl,et al. Autophagy is the dominant type of programmed cell death in breast cancer MCF-7 cells exposed to AGS 115 and EFDAC, new sesquiterpene analogs of paclitaxel , 2005, Anti-cancer drugs.
[192] B. Winblad,et al. Levels of mTOR and its downstream targets 4E‐BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain , 2005, The FEBS journal.
[193] Kenneth Maiese,et al. Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease , 2005, Brain Research Reviews.
[194] C. Johannessen,et al. Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1 , 2005, Molecular and Cellular Biology.
[195] M. Paccalin,et al. mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP‐PS1 transgenic models and in patients with Alzheimer's disease , 2005, Journal of neurochemistry.
[196] K. Maiese,et al. mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways. , 2005, Current neurovascular research.
[197] J. Avruch,et al. Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency* , 2005, Journal of Biological Chemistry.
[198] H. Inoue,et al. Rb1cc1 is critical for myoblast differentiation through Rb1 regulation , 2005, Virchows Archiv.
[199] C. Proud,et al. The Tuberous Sclerosis Protein TSC2 Is Not Required for the Regulation of the Mammalian Target of Rapamycin by Amino Acids and Certain Cellular Stresses* , 2005, Journal of Biological Chemistry.
[200] Paul Tempst,et al. Phosphorylation and Functional Inactivation of TSC2 by Erk Implications for Tuberous Sclerosisand Cancer Pathogenesis , 2005, Cell.
[201] R. Ravid,et al. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology , 2005, Journal of neurochemistry.
[202] H. Lane,et al. The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 Translation , 2005, Cell.
[203] K. Inoki,et al. The Stress-inducted Proteins RTP801 and RTP801L Are Negative Regulators of the Mammalian Target of Rapamycin Pathway* , 2005, Journal of Biological Chemistry.
[204] Xianglin Shi,et al. Induction of a cell stress response gene RTP801 by DNA damaging agent methyl methanesulfonate through CCAAT/enhancer binding protein. , 2005, Biochemistry.
[205] D. Guertin,et al. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.
[206] D. Hedley,et al. Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts. , 2005, Cancer research.
[207] K. Maiese,et al. Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease , 2005, Progress in Neurobiology.
[208] M. Mallat,et al. Phagocytosis in the developing CNS: more than clearing the corpses , 2005, Current Opinion in Neurobiology.
[209] J. Fawcett,et al. Axonal Protein Synthesis and Degradation Are Necessary for Efficient Growth Cone Regeneration , 2005, The Journal of Neuroscience.
[210] K. Maiese,et al. New avenues of exploration for erythropoietin. , 2005, JAMA.
[211] Manuel Hidalgo,et al. Inhibition of mTOR Activity Restores Tamoxifen Response in Breast Cancer Cells with Aberrant Akt Activity , 2004, Clinical Cancer Research.
[212] E. Hafen,et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. , 2004, Genes & development.
[213] Eric R. Kandel,et al. Activated CREB Is Sufficient to Overcome Inhibitors in Myelin and Promote Spinal Axon Regeneration In Vivo , 2004, Neuron.
[214] G. Kroemer,et al. Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma , 2004, Apoptosis.
[215] R. Loewith,et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.
[216] K. Mishima,et al. Inhibition of poly (ADP-ribose) polymerase and caspase-3, but not caspase-1, prevents apoptosis and improves spatial memory of rats with twice-repeated cerebral ischemia. , 2004, Life sciences.
[217] Andrew K Godwin,et al. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth , 2004, Oncogene.
[218] S. Capaccioli,et al. Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt , 2004, Oncogene.
[219] D. Guertin,et al. Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.
[220] I. Gout,et al. The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins , 2004, The Journal of cell biology.
[221] K. Maiese,et al. Essential cellular regulatory elements of oxidative stress in early and late phases of apoptosis in the central nervous system. , 2004, Antioxidants & redox signaling.
[222] E. Raymond,et al. Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[223] Francesco Scaravilli,et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.
[224] K. Maiese,et al. Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system. , 2004, Histology and histopathology.
[225] J. Avruch,et al. Dissociation of raptor from mTOR is a mechanism of rapamycin‐induced inhibition of mTOR function , 2004, Genes to cells : devoted to molecular & cellular mechanisms.
[226] Lewis C Cantley,et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[227] T. Gardner,et al. Insulin Promotes Rat Retinal Neuronal Cell Survival in a p70S6K-dependent Manner* , 2004, Journal of Biological Chemistry.
[228] F. Blankenberg,et al. Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radiolabeled annexin V , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[229] Hyejin Kang,et al. Translational Control by MAPK Signaling in Long-Term Synaptic Plasticity and Memory , 2004, Cell.
[230] J. Blenis,et al. mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E , 2004, Molecular and Cellular Biology.
[231] S. Ceman,et al. Phosphorylation influences the translation state of FMRP-associated polyribosomes. , 2003, Human molecular genetics.
[232] K. Inoki,et al. TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.
[233] K. Maiese,et al. The Tyrosine Phosphatase SHP2 Modulates MAP Kinase p38 and Caspase 1 and 3 to Foster Neuronal Survival , 2003, Cellular and Molecular Neurobiology.
[234] K. Maiese,et al. Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity , 2003, Journal of neuroscience research.
[235] K. Maiese,et al. Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. , 2003, Molecular pharmacology.
[236] J. Fawcett,et al. Inhibiting cell proliferation during formation of the glial scar: effects on axon regeneration in the CNS , 2003, Neuroscience.
[237] C. Proud,et al. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. , 2003, The Biochemical journal.
[238] K. Maiese,et al. Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. , 2003, Trends in pharmacological sciences.
[239] D. Rubinsztein,et al. Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy. , 2003, Human molecular genetics.
[240] A. Cuadrado,et al. Nerve Growth Factor Protects against 6-Hydroxydopamine-induced Oxidative Stress by Increasing Expression of Heme Oxygenase-1 in a Phosphatidylinositol 3-Kinase-dependent Manner* , 2003, The Journal of Biological Chemistry.
[241] K. Maiese,et al. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase‐mediated pathways , 2003, British journal of pharmacology.
[242] K. Maiese,et al. Apaf-1, Bcl-xL, Cytochrome c, and Caspase-9 Form the Critical Elements for Cerebral Vascular Protection by Erythropoietin , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[243] K. Maiese,et al. Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8 , 2003, Journal of neuroscience research.
[244] Kenneth Maiese,et al. Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases , 2002, Circulation.
[245] Tian Xu,et al. Akt regulates growth by directly phosphorylating Tsc2 , 2002, Nature Cell Biology.
[246] J. Crespo,et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. , 2002, Molecular cell.
[247] K. Inoki,et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.
[248] B. Monia,et al. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells , 2002, Oncogene.
[249] D. Sabatini,et al. mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.
[250] J. Avruch,et al. Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.
[251] S. Bodine,et al. Control of Ser2448 Phosphorylation in the Mammalian Target of Rapamycin by Insulin and Skeletal Muscle Load* , 2002, The Journal of Biological Chemistry.
[252] P. Dennis,et al. Quick guide: target of rapamycin. , 2002, Current biology : CB.
[253] K. Maiese,et al. Nicotinamide Modulates Mitochondrial Membrane Potential and Cysteine Protease Activity during Cerebral Vascular Endothelial Cell Injury , 2002, Journal of Vascular Research.
[254] Carmen Socaciu,et al. Kinetics of apoptotic markers in exogeneously induced apoptosis of EL4 cells , 2002, Journal of cellular and molecular medicine.
[255] A. Gingras,et al. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[256] J. Darnell,et al. Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.
[257] A. Marette,et al. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. , 2001, The Journal of biological chemistry.
[258] K. Maiese. The dynamics of cellular injury: transformation into neuronal and vascular protection. , 2001, Histology and histopathology.
[259] K. Maiese,et al. Group I and Group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection , 2000, Journal of neuroscience research.
[260] K. Maiese,et al. Prevention of Nitric Oxide-Induced Neuronal Injury Through the Modulation of Independent Pathways of Programmed Cell Death , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[261] K. Peyrollier,et al. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport. , 2000, The Biochemical journal.
[262] K. Maiese,et al. Critical Temporal Modulation of Neuronal Programmed Cell Injury , 2000, Cellular and Molecular Neurobiology.
[263] A. Schroit,et al. Phosphatidylserine expression on cell surfaces promotes antibody-dependent aggregation and thrombosis in beta2-glycoprotein I-immune mice. , 2000, Journal of autoimmunity.
[264] K. Maiese,et al. Membrane asymmetry and DNA degradation: functionally distinct determinants of neuronal programmed cell death , 2000, Journal of neuroscience research.
[265] Weiping Yuan,et al. Glucose-induced autophagy of peroxisomes in Pichia pastoris requires a unique E1-like protein. , 1999, Molecular biology of the cell.
[266] K. Maiese,et al. Direct Temporal Analysis of Apoptosis Induction in Living Adherent Neurons , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[267] Linda N. Liu,et al. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. , 1999, Cancer research.
[268] K. Maiese,et al. Metabotropic glutamate receptor subtypes independently modulate neuronal intracellular calcium , 1999, Journal of neuroscience research.
[269] K. Maiese,et al. Nitric oxide induction of neuronal endonuclease activity in programmed cell death. , 1999, Experimental cell research.
[270] K. Maiese,et al. Metabotropic Glutamate Receptors Prevent Programmed Cell Death through the Modulation of Neuronal Endonuclease Activity and Intracellular pH , 1999, Experimental Neurology.
[271] R. Roth,et al. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[272] Tomohiko Maehama,et al. The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.
[273] A. Gingras,et al. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. , 1998, Genes & development.
[274] F. McCormick,et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. , 1998, Science.
[275] K. Maiese,et al. Neuroprotection of Lubeluzole Is Mediated Through the Signal Transduction Pathways of Nitric Oxide , 1997, Journal of neurochemistry.
[276] J. Anders,et al. Transplanted Glial Scar Impedes Olfactory Bulb Reinnervation , 1996, Experimental Neurology.
[277] R. Pearson,et al. The principal target of rapamycin‐induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. , 1995, The EMBO journal.
[278] Nahida Matta,et al. CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain , 1995, Neuron.
[279] S. Schreiber,et al. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[280] K. Maiese,et al. Neuroprotection by Peptide Growth Factors against Anoxia and Nitric Oxide Toxicity Requires Modulation of Protein Kinase C , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[281] A. Meijer,et al. Phosphorylation of Ribosomal Protein S6 Is Inhibitory for Autophagy in Isolated Rat Hepatocytes (*) , 1995, The Journal of Biological Chemistry.
[282] K. Fenger,et al. Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families. , 1993, Human molecular genetics.
[283] K. Maiese,et al. Protein kinases modulate the sensitivity of hippocampal neurons to nitric oxide toxicity and anoxia , 1993, Journal of neuroscience research.
[284] T. Tsai,et al. Paeonol attenuates H₂O₂-induced NF-κB-associated amyloid precursor protein expression. , 2010, The American journal of Chinese medicine.
[285] P. Beart,et al. Multifaceted deaths orchestrated by mitochondria in neurones. , 2010, Biochimica et biophysica acta.
[286] D. Rubinsztein,et al. Autophagic clearance of aggregate-prone proteins associated with neurodegeneration. , 2009, Methods in enzymology.
[287] V. Deretic,et al. Monitoring autophagy during Mycobacterium tuberculosis infection. , 2009, Methods in enzymology.
[288] Michael Karin,et al. p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling , 2009, Cell.
[289] W. Weichert,et al. Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis. , 2008, Oncology reports.
[290] M. Konopleva,et al. The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML , 2008, Leukemia.
[291] S. Dulchavsky,et al. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells. , 2008, Journal of experimental therapeutics & oncology.
[292] S. Majd,et al. Fibrillar beta-amyloid (Abeta) (1-42) elevates extracellular Abeta in cultured hippocampal neurons of adult rats. , 2007, Brain research.
[293] W. Tetzlaff,et al. Changes in cytoskeletal protein synthesis following axon injury and during axon regeneration , 2007, Molecular Neurobiology.
[294] K. Maiese,et al. Winding through the WNT pathway during cellular development and demise. , 2006, Histology and histopathology.
[295] K. Maiese,et al. Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB. , 2006, Current neurovascular research.
[296] H. Lane,et al. The mTOR Inhibitor RAD 001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p 21 Translation , 2005 .
[297] K. Maiese,et al. Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better? , 2005, Current neurovascular research.
[298] K. Maiese,et al. Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. , 2005, Current neurovascular research.
[299] D. Hardie,et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.
[300] K. Maiese,et al. Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. , 2005, Histology and histopathology.
[301] A. Privat,et al. Glial scar and axonal regeneration in the CNS: lessons from GFAP and vimentin transgenic mice. , 2004, Acta neurochirurgica. Supplement.
[302] K. Maiese,et al. Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease. , 2004, Restorative neurology and neuroscience.
[303] R. Abraham. mTOR as a positive regulator of tumor cell responses to hypoxia. , 2004, Current topics in microbiology and immunology.
[304] William R Sellers,et al. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. , 2003, Cancer treatment and research.
[305] K. Maiese,et al. Metabotropic glutamate receptors promote neuronal and vascular plasticity through novel intracellular pathways. , 2003, Histology and histopathology.
[306] K. Maiese,et al. The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells. , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[307] D. Klionsky,et al. Autophagy, cytoplasm-to-vacuole targeting pathway, and pexophagy in yeast and mammalian cells. , 2000, Annual review of biochemistry.
[308] D. Kwiatkowski,et al. Tuberous sclerosis. , 1994, Archives of dermatology.
[309] P. Reier,et al. The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. , 1988, Advances in neurology.
[310] O. Hino,et al. Neuromuscular abundance of RB 1 CC 1 contributes to the non-proliferating enlarged cell phenotype through both RB 1 maintenance and TSC 1 degradation , 2022 .